We have previously demonstrated that the in vivo adoptive secondary antibody response to 2,4-dinitrophenyl-ovalbumin (DNP-OVA)1 in mice involves the synergistic activity of two distinct helper T cells (1-4). One of these helper T cells is specific for antigen and is thought to be major histocompatibility complex (MHC) restricted in its activity. It requires a hapten-carrier bridge for its function and is absolutely required for in vivo anti-hapten antibody responses in our system (5). The other helper T cell is also specific for antigen, but it does not require a hapten-carrier bridge (5). The second cell is not found in mice treated from birth with anti-/~ chain antibody, which led us to propose that this cell actually recognizes B cells directly via their immunoglobulin (Ig) receptor (4). Both helper T cells are Lyt-l÷,2 -(5). The action of the Ig-recognizing helper T cell is transient in secondary antibody responses (1-4). Thus, its major effects are seen by 5-7 d after boosting in adoptive transfer experiments, whereas by 10-12 d, its effects are no longer apparent.
have been previously characterized in our laboratories (16) (17) (18) (19) . The present experiments demonstrate several interesting points about Id-460. First, expression of Id-460 in serum varies markedly with time after immunization, often peaking very shortly after boosting, and then falling rapidly. Second, the anti-DNP response does not parallel the expression of Id-460 in serum or in splenic plaque-forming cells (PFC). Third, Id-460 expression shows no apparent restriction to any of the isotypes (IgM, IgE, IgG2a, and IgG1) that we have measured. Rather, it would appear that Id-460 + clones are selectively activated early in secondary anti-DNP antibody responses, possibly reflecting the activity of Id-460-specific helper T cells. Later, Id-460-antibody predominates in this response. The genetic and cellular basis of this complex regulatory process will be examined in subsequent experiments.
Materials and Methods
Methods Previously Described. Mice, antigens, myeloma proteins, antisera, immunizations, and radioimmunoassays for Id-460 and for anti-DNP antibody are all as previously described (19) .
Hemolytic Plaque Assa 5. Spleen cells were assayed for direct, indirect, and specifc subclass anti-TNP PFC and for Id-460 + PFC by the Cunningham and Szenberg modification of the Jerne plaque technique (20) . Trinitrophenylated sheep erythrocytes (TNP-SRBC) were prepared as follows: 1 ml packed SRBC (Colorado Serum Co., Denver, Colo.) were mixed with 4 ml 10 mM trinitrobenzenesulfonic acid in phosphate-buffered saline (PBS), pH 7.4, at 37°C for 12 min and washed extensively with PBS (21) . TNP-SRBC were used as 1% suspension in RPMI 1640 medium buffered with 10 mM Hepes. Guinea pig serum, as a source of complement, was absorbed on TNP-SRBC to remove hemolytic antibody. All dilutions were done in RPMI 1640.
The use of various plaque-developing or -inhibiting antisera was required for quantitation of direct, indirect (specific subclass), and Id-460 + plaques. Direct plaques were inhibited by goat anti-mouse IgM antiserum. Anti-/z chain antibody was produced in a goat twice immunized with 100 /zg MOPC 104E in complete Freund's adjuvant (CFA) given immediately after intravenous injection of 5 mg DEAE-purified mouse Ig (MIg). Immunoelectrophoresis has shown this antiserum to be specific for mouse IgM. Nonspecific developing activities were eliminated by passage of the antiserum over a Sepharose immunoadsorbent column consisting of an IgA and a variety of IgG myeloma proteins (McPC 603, MOPC 31c, MPC 11, FLOPC 21, and MOPC 173).
Developing antiserum for indirect PFC was obtained from rabbits immunized intraperitoneally with 1 mg of DEAE-purified MIg in CFA, followed 2 wk later by an intravenous boost of 4 mg alum-precipitated MIg. To remove nonspecific activity, the antiserum was absorbed on TNP-SRBC. For development of individual IgG subclass PFC, Richard Asofsky (National Institute of Allergy and Infectious Diseases, National Institutes of Health) kindly provided rabbit anti-mouse IgG1, and anti-IgG2, antisera. Titrations were performed on all antisera to determine the dilution at which maximum activity was attained.
Q uantitation of Id-460 + PFC was accomplished through inhibition of anti-TNP PFC by rabbit anti-Id-460 antiserum. Immunization procedures and characterization of this antiserum are as previously described (19) . Genetic studies performed on immune sera by competitive inhibition radioimmunoassays have shown this antiserum to be specific for Id-460 expression. 
Results
Levels of Id-460 and Anti-DNP Antibody Are Independently Regulated. In the previous paper (19) , responses to DNP-OVA in several strains of mice were shown. The timecourse of such a response in BALB/c and BALB.K mice is shown in Fig. 1 . Low levels of Id-460 are formed in the primary response to DNP-OVA. However, the secondary response is marked by a rapid and early rise in Id-460 levels, which is paralleled by a rapid and early rise in total anti-DNP antibody. Subsequently, Id-460 levels fall sharply and may increase again (BALB.K), whereas the anti-DNP antibody response reaches and maintains high levels. Thus, it would appear that Id-460 levels and anti-DNP levels in the serum may not be regulated in precisely the same fashion. Rather, there would appear to be idiotype-specific regulation of Id-460 levels in this response. However, serum anti-DNP antibody and Id-460 levels represent the complex outcome of production and catabolism; a more detailed analysis of this response was performed at the antibody-forming cell level.
Transient Dominance of the Anti-DNP PFC Response by Id-460.
Because of the dramatic regulatory events apparent from assays of serum Id-460 levels in the secondary anti-DNP-OVA respone (19; Fig. 1 ), we have carefully analyzed splenic PFC for isotype and Id-460 according to the techniques outlined in Materials and Methods (Table I) . Using various inhibitory and developing antisera, we can readily identify PFC producing anti-DNP of three isotypes as well as the production of Id-460 + anti-DNP antibody of each isotype. The results in Fig. 2 are typical of this response, and show experiments in two strains of mice typed as Id-460 + in our previous genetic analysis of this response, BALB/c and BALB.K (19) . Two points are made by these experiments: first, in both strains of mice there is an early increase in Id-460 + PFC, and in some cases, up to 80-100% of the PFC of a given isotype may be Id-460 +. This dominance of the splenic PFC response correlates well with the data obtained by radioimmunoassay of serum Id-460. Second, the dominance of Id-460 + PFC is a transient phenomenon, because by day 7-10 of the response, Id-460 + PFC have fallen to low levels. Thus, anti-DNP antibody production and Id-460 production are not regulated in parallel either in serum or as observed with splenic PFC. Subsequent experiments confirm these results in general. Peak Id-460 + PFC responses occur early after boosting immunization but do not always occur on the same day from experiment to experiment. Id-460 + PFC (direct plus indirect PFC) usually account for 52-91% of anti-DNP PFC seen between days 3 and 5, whereas minimum percentages of these plaques are seen days 7 and 10. A summary of maximum and minimum percentages of Id-460 + PFC in several experiments is shown in Table II (22) . In most systems, these idiotypes make up a stable proportion of the response. Thus, the response to PC in BALB/c mice is >95% T15-Id + (23, 24) . Responses to streptococcal A carbohydrate (25) and to p-azophenylarsonate (26) in A/J mice each have 20-70% antibody bearing a major, crossreactive idiotype. In contrast, certain idiotypes are found only in individual or small numbers of mice (27) or not at all in immune responses of normal mice (18) , The only previous idiotype showing transient dominance of a response are those of C57BL/6 (28) and BALB/c (29) mice to the hapten 3-nitro-4-hydroxyphenylacetyl, in which the primary response is dominated by antibody bearing an inherited idiotype and ?~ light chains, but hyperimmune antibodies are r and idiotype negative (29) . Id-460 shows a transient dominance in the secondary anti-DNP response and is the predominant idiotype expressed in serum early in the response.
In this paper, the phenomenon of transient dominance of Id-460 expression during in vivo anti-DNP antibody responses in normal mice is strikingly demonstrated by measuring splenic anti-TNP PFC. The percentage of Id-460 + PFC reaches an early maximum about 5 d after boosting, whereas the concentration of serum Id-460 usually peaks around day 7-10. It would appear that there is a preferential production of anti-DNP antibody bearing Id-460 early in the secondary response. The time-course of Id-460 expression correlates well with the time-course of action of a second helper T cell that has been observed shortly after boosting in adoptive transfer experiments and is missing in mice treated with anti-# chain antibody in the DNP system (4). Such treatment has been shown to deplete idiotype-specific helper T cells in other experiments (8) . We would propose that the transient expression of Id-460 reflects the early action of such Ig-dependent helper T cells. This suggests the presence of some type of idiotype-anti-idiotype interaction and the existence of an Id-460 recognizing helper T cell. Furthermore, we have proposed (15) that this same cell also induces suppressor T cells via the heavy-chain variable-region-restricted pathway defined by Eardley et al. (30) , and thus its action may be twofold. First, it induces Id-460 + B cells selectively, and second, it activates suppressor T cells via an idiotype-anti-idiotype pathway potentially leading to the inactivation of such Id-460-bearing B cells. The result of such a complex interaction would be the transient idiotypic dominance that was in fact observed. The validity of this interpretation is now being tested at the cellular level.
The data presented also show that Id-460 is not restricted in its expression to particular isotypes, although IgM and IgGa are the major isotypes represented. Id-460 is found associated essentially equally in the three isotypes, IgM, IgG1, and IgG2a, that we have studied at the PFC level. We have also found parallel expression of Id-460 levels by radioimmunoassay and IgE anti-DNP antibody by passive cutaneous anaphylaxis. In preliminary experiments we find that some, but not all, of the IgE in this response can be neutralized by anti-Id-460 (unpublished results).
Because Id-460 expression is not restricted to particular isotypes, idiotypic regulation cannot by itself account for isotypic regulation in this system. Rather, the pattern observed is one in which cycling occurs. Id-460 + PFC switch from IgM to IgG and are followed by a wave of Id-460-PFC, again switching from IgM to IgG. Late in the response, as the total number of anti-DNP PFC decreases, the proportion of Id-460 + PFC are often observed to increase. We have no evidence to suggest that the Id-460-PFC arise from the Id-460 + population. Instead, it would appear at present that Id-460 + PFC are active early in the response and can be regulated independently of the Id-460-PFC or the total anti-DNP PFC response.
These results would appear to conflict with those obtained previously both in these laboratories (18) and those of Bona and Paul (31) and Bona and co-workers (32) . There are several possible explanations for these differences. First, the antigen and schedule of immunization was different; Zeldis et al. (18) used DNP-bovine gamma globulin in CFA, and measured serum Id-460 at day 10 of the secondary response, whereas Bona and Paul (31) and Bona et al. (32) used TNP on various T-independent carriers in vivo or in vitro, and measured PFC at day 3 of the primary response. Given the extreme variability in Id-460 expression we have observed, it is not surprising that such changes in protocol might influence the percent Id-460 + antibody detected. However, the more likely explanation for the differences between the present results and those of Bona and Paul (31) and Bona et al. (32) lies in the anti-idiotypic reagents used. Bona et al. used mouse anti-Id-460, which is not characterized in terms of light-chain genetics or binding-site specificity, whereas we used a site-specific rabbit anti-Id-460 that detects a determinant, the expression of which is regulated by genes mapping to both Igh-V ang IgK-V. Even more significant is the finding 2 that our anti-Id-460 detects Id-460 in the serum of all strains of normal mice thus far tested, and in significant amounts. Thus, it is unlikely that mouse anti-Id-460 would detect the determinant(s) on MOPC 460 measured in our studies. Indeed, one might almost predict from the serology alone that the results in these studies would differ. Nonetheless, all three sets of studies agree in finding that anti-DNP antibody can express significant amounts of Id-460 in BALB/c mice.
We are currently studying the cellular, genetic, and environmental factors that contribute to this transient idiotypic dominance. Besides idiotype-specific helper T cells, we are testing the role of the Id-460-specific suppressor T cell described by Bona and Paul (31) as regulating in vitro anti-TNP responses in our system. Because of the great variability of Id-460 expression, characterization of this response has proven to be more difficult than with other more stably dominated responses. One critical factor in dominant expression of Id-460 may be the finding of large amounts of Id-460 +, non-DNP-binding material in serum from nonimmune mice (33) .2 This material may play a role in establishing the idiotypic cell interactions for the Id-460 response.
Summary
After immunization of mice with 2,4-dinitrophenyl-ovalbumin (DNP-OVA), it was shown previously that strains having Igh-V a genes and able to express light chains of the V~ 1 group produce high levels of anti-DNP antibody bearing an idiotype (Id-460) associated with the combining site of the BALB/c DNP-binding myeloma protein MOPC 460. Expression of Id-460 in serum is transient; Id-460 levels peak early in the response and are regulated independently of total anti-DNP antibody. In this paper, the transient dominance of Id-460 expression has been confirmed at the cellular level by inhibition of splenic anti-DNP plaque-forming cells (PFC) with rabbit anti-Id-460 antiserum. Id-460 ÷ PFC can account for 52-91% of anti-DNP PFC early after secondary challenge with DNP-OVA. Furthermore, Id-460 is represented at these high levels in IgM, IgG1, and IgG2a, the three isotypes tested in the PFC assay, as well as in IgE, as tested by passive cutaneous anaphylaxis. Thus, there is no preferential association of Id-460 with a given isotype. We conclude from these studies that Id-460 is a dominant idiotype in the anti-DNP antibody response of BALB/c mice to DNP-OVA. This dominance is expressed transiently and is independent of isotype. A further conclusion from these studies is that regulation of isotype expression is independent of the regulation of idiotype expression in this system. We would suggest that regulation of Id-460 expression involves Ig-dependent helper T cells specific for Id-460 that induce Id-460 ÷ B cells and also activate suppressor T cells, both events occurring via idiotype-anti-idiotype interactions.
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